Observational Study on Chronic Myeloid Leukemia Patients in Any Phase Treated With Ponatinib (Iclusig®) at Any Dose

NCT03933852 · clinicaltrials.gov ↗
UNKNOWN
Status
100
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

University of Jena